Skip to main content

Advertisement

Log in

A complex interplay between autonomic symptoms and symptoms of depression, anxiety, and stress

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

We evaluated the influence of symptoms of depression, anxiety, and stress on the results of COMPASS-31 in a large population of people referred to the head-up tilt test (HUTT) and healthy controls (HC).

Methods

Nine hundred fifty-nine consecutive patients referred to HUTT and 518 HC were enrolled. All participants completed Composite Autonomic Symptom Score-31 (COMPASS-31). Stress symptoms were evaluated by Depression, Anxiety, and Stress-21 (DASS-21) questionnaire. We corrected the result of the COMPASS-31 with the independent predictors in order to improve the specificity of the test.

Results

In both patients and HC, COMPASS-31 was higher in participants with depression, anxiety, and stress symptoms (all p < 0.001). In a multivariable linear regression analysis, HC was negative, while female sex and symptoms of depression, anxiety, and stress were independent positive predictors of COMPASS-31. In HC, COMPASS-31 had a median of 7.913, and this value differentiated between HC and patients with a high sensitivity of 87% and low specificity of 50%. In order to adjust the value of COMPASS-31 with the parameters that were significant in the multivariable linear regression model, we calculated the new corrected COMAPSS-31 (cCOMPASS-31), which had comparable sensitivity of 77%, but an increased specificity of 73%.

Conclusion

This study has shown that symptoms of depression, anxiety, and/or stress worsen the perceived severity of autonomic symptoms in people with symptoms of orthostatic intolerance and healthy population. cCOMPASS-31 is a valuable tool that can help clinicians in discerning the true autonomic background of patients’ complaints.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS-31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 87:1196–1201

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ruška B, Pavičić T, Pavlović I, Junaković A, Adamec I, Crnošija L, Krbot Skorić M, Habek M (2018) Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting. Neurol Sci 39:2079–2084

    Article  PubMed  Google Scholar 

  3. Kim Y, Seok JM, Park J, Kim K-H, Min J-H, Cho JW, Park S, Kim HJ, Kim BJ, Youn J (2017) The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism. PLoS One 12:e0180744

    Article  PubMed  PubMed Central  Google Scholar 

  4. Krbot Skorić M, Crnošija L, Gabelić T, Barun B, Adamec I, Junaković A, Pavičić T, Ruška B, Habek M (2019) Autonomic symptom burden can predict disease activity in early multiple sclerosis. Mult Scler Relat Disord 28:250–255

    Article  PubMed  Google Scholar 

  5. Treister R, O'Neil K, Downs HM, Oaklander AL (2015) Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy. Eur J Neurol 22:1124–1130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kang JH, Kim JK, Hong SH, Lee CH, Choi BY (2016) Heart rate variability for quantification of autonomic dysfunction in fibromyalgia. Ann Rehabil Med 40:301–309

    Article  PubMed  PubMed Central  Google Scholar 

  7. Greco C, Di Gennaro F, D'Amato C, Morganti R, Corradini D, Sun A, Longo S, Lauro D, Pierangeli G, Cortelli P, Spallone V (2017) Validation of the composite autonomic symptom score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes. Diabet Med 34:834–838

    Article  CAS  PubMed  Google Scholar 

  8. Rea NA, Campbell CL, Cortez MM (2017) Quantitative assessment of autonomic symptom burden in postural tachycardia syndrome (POTS). J Neurol Sci 377:35–41

    Article  PubMed  Google Scholar 

  9. Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792

    Article  CAS  PubMed  Google Scholar 

  10. Krbot Skorić M, Crnošija L, Adamec I, Barun B, Gabelić T, Smoljo T, Stanić I, Pavičić T, Pavlović I, Drulović J, Pekmezović T, Habek M (2019) Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue. Clin Auton Res 29:321–328

    Article  PubMed  Google Scholar 

  11. Raj V, Opie M, Arnold AC (2018) Cognitive and psychological issues in postural tachycardia syndrome. Auton Neurosci 215:46–55

    Article  PubMed  PubMed Central  Google Scholar 

  12. Anderson JW, Lambert EA, Sari CI, Dawood T, Esler MD, Vaddadi G, Lambert GW (2014) Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Front Physiol 5:230

    Article  PubMed  PubMed Central  Google Scholar 

  13. McGrady A, Kern-Buell C, Bush E, Khuder S, Grubb BP (2001) Psychological and physiological factors associated with tilt table testing for neurally mediated syncopal syndromes. Pacing Clin Electrophysiol 24:296–301

    Article  CAS  PubMed  Google Scholar 

  14. Cohen TJ, Thayapran N, Ibrahim B, Quan C, Quan W, von zur Muhlen F. (2000) An association between anxiety and neurocardiogenic syncope during head-up tilt table testing. Pacing Clin Electrophysiol 23:837–841

    Article  CAS  PubMed  Google Scholar 

  15. Giada F, Silvestri I, Rossillo A, Nicotera PG, Manzillo GF, Raviele A (2005) Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncope. Europace 7:465–471

    Article  PubMed  Google Scholar 

  16. Oei TP, Sawang S, Goh YW, Mukhtar F (2013) Using the depression anxiety stress scale 21 (DASS-21) across cultures. Int J Psychol 48:1018–1029

    Article  PubMed  Google Scholar 

  17. Henry JD, Crawford JR (2005) The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44:227–239

    Article  PubMed  Google Scholar 

  18. Ng F, Trauer T, Dodd S, Callaly T, Campbell S, Berk M (2007) The validity of the 21-item version of the depression anxiety stress scales as a routine clinical outcome measure. Acta Neuropsychiatr 19:304–310

    Article  PubMed  Google Scholar 

  19. Drulović J, Gavrilović A, Crnošija L, Kisić-Tepavčević D, Krbot Skorić M, Ivanović J, Adamec I, Dujmović I, Junaković A, Marić G, Martinović V, Pekmezović T, Habek M (2017) Validation and cross-cultural adaptation of the COMPASS-31 in Croatian and Serbian patients with multiple sclerosis. Croat Med J 58:342–348

    Article  PubMed  Google Scholar 

  20. Reić Ercegovac I, Penezić Z (2012) Skala depresivnosti, anksioznosti i stresa (DASS) (depression, anxiety and stress scale). In: Proroković A, Ćubela Adorić V, Penezić Z, Tucak Junaković I (eds) Zbirka psihologijskih skala i upitnika, vol 6. University of Zadar, pp 17–23

    Google Scholar 

  21. Thijs RD, Brignole M, Falup-Pecurariu C, Fanciulli A, Freeman R, Guaraldi P, Jordan J, Habek M, Hilz M, Traon AP, Stankovic I, Struhal W, Sutton R, Wenning G, Van Dijk JG (2021) Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness: consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN). Clin Auton Res 31:369–384

    Article  PubMed  PubMed Central  Google Scholar 

  22. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72

    Article  PubMed  Google Scholar 

  23. DiRenzo D, Russell J, Bingham CO 3rd, McMahan Z (2021) The relationship between autonomic dysfunction of the gastrointestinal tract and emotional distress in patients with systemic sclerosis. J Clin Rheumatol. 27:11–17

    Article  PubMed  PubMed Central  Google Scholar 

  24. Martinez J, Palma JA, Norcliffe-Kaufmann L, Garakani A, Kaufmann H (2020) Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials. Clin Auton Res 30:215–221

    Article  PubMed  PubMed Central  Google Scholar 

  25. Da Silva H, Pardaens S, Vanderheyden M, De Sutter J, Demeyer H, De Pauw M, Demulier L, Stautemas J, Calders P (2021) Autonomic symptoms and associated factors in patients with chronic heart failure. Acta Cardiol 9:1–9

    Google Scholar 

  26. Ader R, Cohen N, Felten D (1995) Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345:99–103

    Article  CAS  PubMed  Google Scholar 

  27. Won E, Kim YK (2016) Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression. Curr Neuropharmacol 14:665–673

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Jarrett ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM (2003) Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci 48:386–394

    Article  PubMed  Google Scholar 

  29. Choi JW, Thakur H, Cohen JR (2021) Cardiac autonomic functioning across stress and reward: links with depression in emerging adults. Int J Psychophysiol 168:1–8

    Article  PubMed  Google Scholar 

  30. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW (2008) Association between major depressive disorder and heart rate variability in the Netherlands study of depression and anxiety (NESDA). Arch Gen Psychiatry 65:1358–1367

    Article  PubMed  Google Scholar 

  31. Ginsberg JP (2016) Editorial: Dysregulation of autonomic cardiac control by traumatic stress and anxiety. Front Psychol 7:945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Steffen PR, Fidalgo L, Schmuck D, Tsui Y, Brown T (2014) Psychotherapy participants show increased physiological responsiveness to a lab stressor relative to matched controls. Front Psychol 5:795

    Article  PubMed  PubMed Central  Google Scholar 

  33. Teed AR, Feinstein JS, Puhl M, Lapidus RC, Upshaw V, Kuplicki RT, Bodurka J, Ajijola OA, Kaye WH, Thompson WK, Paulus MP, Khalsa SS (2022) Association of generalized anxiety disorder with autonomic hypersensitivity and blunted ventromedial prefrontal cortex activity during peripheral adrenergic stimulation: a randomized clinical trial. JAMA Psychiatry 79:323–332

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: Habek. Acquisition of data: Junaković, Skočić Hanžek, Adamec, Krbot Skorić, Habek. Analysis and interpretation of data: Junaković, Skočić Hanžek, Adamec, Krbot Skorić, Habek. Drafting of the manuscript: Habek. Critical revision of the manuscript for important intellectual content: Junaković, Skočić Hanžek, Adamec, Krbot Skorić, Habek. Administrative, technical, and material support: Junaković, Skočić Hanžek, Adamec, Krbot Skorić, Habek.

Corresponding author

Correspondence to Mario Habek.

Ethics declarations

Ethical approval

The study protocol was approved by the ethical committees of the University Hospital Center Zagreb and the University of Zagreb, School of Medicine (class: 8.1-19/74-2; number: 02/21 AG).

Conflict of interest

AJ: nothing to disclose.

MSH: nothing to disclose.

IA: participated as a clinical investigator and/or received consultation and/or speaker fees from Biogen, Sanofi Genzyme, Merck, Bayer, Novartis, Pliva/Teva, Roche, Alvogen, Actelion, Alexion Pharmaceuticals, and TG Pharmaceuticals.

MKS: received consultation and/or speaker fees from Sanofi Genzyme and Roche.

MH: participated as a clinical investigator and/or received consultation and/or speaker fees from Biogen, Sanofi Genzyme, Merck, Bayer, Novartis, Pliva/Teva, Roche, Alvogen, Actelion, Alexion Pharmaceuticals, and TG Pharmaceuticals.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Junaković, A., Skočić Hanžek, M., Adamec, I. et al. A complex interplay between autonomic symptoms and symptoms of depression, anxiety, and stress. Neurol Sci 44, 3169–3179 (2023). https://doi.org/10.1007/s10072-023-06787-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06787-9

Keywords

Navigation